Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? (Q36762575)

16 August 2017

1 reference

title

Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? (English)

1 reference

16 August 2017

1 reference

1 reference

Francine Garnache-Ottou

series ordinal

1

1 reference

16 August 2017

Jean Feuillard

series ordinal

2

1 reference

16 August 2017

Philippe Saas

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

British Journal of Haematology

16 August 2017

1 reference

16 August 2017

136

1 reference

16 August 2017

4

1 reference

16 August 2017

539-548

1 reference

Ikaros is required for plasmacytoid dendritic cell differentiation

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Origin and filiation of human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Neuropilin-1: a surface marker of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Dendritic cells: a complex simplicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Identification of a novel, human multilymphoid progenitor in cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Redefinition of lymphoid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Co‐expression of vascular endothelial growth factor and its receptor, neuropilin‐1, in a B cell lymphoma cell line (OHK) with primary effusion lymphoma immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Characterization of human blood dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

CD4+ CD56+ blastic tumor cells express CD101 molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

The pathology of NK-cell lymphomas and leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

The role of TCL1 in human T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

What is CD4+CD56+ malignancy and how should it be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

A novel dendritic cell subset involved in tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Identification of the TCL1 gene involved in T-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

WHO-EORTC classification for cutaneous lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

Clinical and biologic features of CD4+CD56+ malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06458.X

10.1111/J.1365-2141.2006.06458.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference